Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹29,609.3
₹62,918 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,541.2
₹31,742 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹510.6
₹8,036 Cr
Pharmaceuticals & Drugs
₹739.8
₹6,705 Cr
Pharmaceuticals & Drugs
₹341.7
₹3,118 Cr
Pharmaceuticals & Drugs
₹266.9
₹2,986 Cr
Pharmaceuticals & Drugs
₹92.8
₹2,382 Cr
Pharmaceuticals & Drugs
₹809.3
₹462 Cr
Pharmaceuticals & Drugs
₹63.4
₹308 Cr
Pharmaceuticals & Drugs
₹36.5
₹103 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,541.2
₹4,532 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹510.6
₹4,145 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹341.7
₹2,330 Cr
Pharmaceuticals & Drugs
₹739.8
₹2,057 Cr
Pharmaceuticals & Drugs
₹266.9
₹628 Cr
Pharmaceuticals & Drugs
₹92.8
₹211 Cr
Pharmaceuticals & Drugs
₹29,609.3
₹6,243 Cr
Pharmaceuticals & Drugs
₹63.4
₹51 Cr
Pharmaceuticals & Drugs
₹809.3
₹360 Cr
Pharmaceuticals & Drugs
₹36.5
₹576 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,541.2
₹898 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹510.6
₹389 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹739.8
₹249 Cr
Pharmaceuticals & Drugs
₹341.7
₹153 Cr
Pharmaceuticals & Drugs
₹92.8
₹142 Cr
Pharmaceuticals & Drugs
₹266.9
₹137 Cr
Pharmaceuticals & Drugs
₹29,609.3
₹1,334 Cr
Pharmaceuticals & Drugs
₹63.4
₹2 Cr
Pharmaceuticals & Drugs
₹809.3
₹40 Cr
Pharmaceuticals & Drugs
₹36.5
₹6 Cr

You may also like the below Video Courses